期刊文献+

四肢恶性黑色素瘤诊治失误24例分析

Research on misdiagnosis and mistreatment with limb malignant melanoma
在线阅读 下载PDF
导出
摘要 目的分析24例四肢恶性黑色素瘤初次在院外就诊时存在诊治缺陷的原因。方法对我科2005年4月~2008年11月收治的24例四肢恶性黑色素瘤患者初次在外院就诊时采取的不正确诊断及治疗措施进行回顾性分析。结果 24例患者均在外院经过初次诊断或治疗,其中11例诊断方式不合理(采用了表面活检或穿刺活检),1例病理检查有误,10例患者手术方式不合理,5例患者治疗方式不完善,10例随访不完善。首诊三级医院11例,首诊二级医院9例,首诊镇级医院1例,首诊校医院诊所1例,首诊私人门诊2例。结论对恶性黑色素瘤最基本的活检以及治疗方法需规范化,对门诊就治的四肢软组织包块应提高警惕,同时应提高初次就诊医院的病理诊断水平。 Objective To analyze the causes of misdiagnosis and mistreatment of 24 patients with limb malignant melanoma.Methods Twenty four cases with limb malignant melanoma were mmisdiagnosised and mistreated in other hospital via once or twice were retrospectively analyzed.Results Studies included a total of 24 patients,female 11,male 13,the average age was 51.9 years(21~85).There were 2 fingers,2 toes,18 feet,and 2 cases in the lower limbs.11 cases existed irregular diagnosis diagnosis and treatment in other hospital,1 case misdiagnosis in pathology,10 cases were irregular surgery,inadequate treatment in 5 cases,incomplete follow-up in 10 cases.There were 11 cases misdiagnosed in the top three hospitals,9 cases in secondary hospitals,1 case in township hospitals,1 case in hospitals and clinics for school,2 cases was private out-patients.Conclusion Although certain aspect of malignant melanoma diagnosis and treatment still exits a certain degree of controversy,the most basic treatment,as well as take biopsy standardize and improve treatment of the initial level of the hospital's pathology are vital important.
出处 《新疆医科大学学报》 CAS 2010年第6期693-695,共3页 Journal of Xinjiang Medical University
关键词 黑色素瘤 四肢 诊治 malignant melanoma limbs misdiagnosis and mistreatment
  • 相关文献

参考文献10

  • 1Rager EL, Bridgeford EP, Ollila DW. Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment [J]. Am Fam Physic,2005, 72:269-276.
  • 2Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision[J]. Arch Surg, 2002, 137 : 1101-1105.
  • 3Thomas JM, Newton-Bishop J, A' Hern R, et al. Excision margins in high-risk malignant melanoma[J]. New Engl J Med, 2004,350:757- 766.
  • 4Atkins MB. Cytokine-based therapy and biochemotherapy for advanced melanoma[J]. Clin Cancer Res, 2006,12(7):2353- 2358.
  • 5Lens MB,Dawes M. Interferon alfa therapy for malignant melanoma : a systematic review of randomized controlled trials[J]. J Clin Oncol, 2002,20 : 1818-1825.
  • 6Roberts DLL,Anstey AV,Barlow RJ. U. K guidelines for the management of cutaneous melanoma[J]. Br J Dermatol,2002, 146:7 -17.
  • 7Garbe C,Eigentler TK. Diagnosis and treatment of cutaneous melanoma : state of the art 2006 [J ]. Melanoma Res, 2007,17 : 117-127.
  • 8Buttner P,Garbe C, Bertz J, et al. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clarkrs level for prognostic elassification[J]. Cancer, 1995, 75:2499.
  • 9Eton O. Chemotherapy, cytokines, and biochemotherapy for melanoma cancer [J]. Chernother Biol Response Modif,2005, 22:739-748.
  • 10Gogas H, loannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon[J]. NewEngl J Med,2006,354(7):709- 718.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部